Topics: COVID-19
Events
-
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
-
Role of Clinical Trial Sponsors & COVID-19: considerations and strategies for running trials during the pandemic
-
AAHMS webinar – COVID-19: Where to from here?
-
Tweetchats with PRAXIS and ACTA
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
News
-
PRAXIS Webinar Managing clinical trials in a time of uncertainty: COVID-19
-
Medical Research Future Fund COVID 19 funding
-
National COVID-19 Clinical Evidence Taskforce: New Clinical Guidelines for COVID-19 to help Australian clinicians deliver best care
-
FDA releases final update on managing clinical trials during COVID-19
-
FIND AND SHARE CLINICAL TRIAL SOLUTIONS AT BEYOND COVID-19: A SOLUTION-FOCUSSED FORUM
-
Vaccines alone won’t keep Australia COVID-safe, review finds
-
NHMRC advice regarding grant administration matters
-
HealthMatch Clinical Trials Tracker – See clinical trials in action during the COVID-19 pandemic
-
Victorian Coordinating Office for Clinical Trial Research update
-
State and Territory Clinical Trials Contacts
-
COVID-19: Queensland Health Operational Guidance for sponsors, trial sites, ethics committees, research governance officer/s and researchers
-
ACTA STInG: signatories to open letters addressing statistical analysis and data integrity in COVID-19 publications
-
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID19 Pandemic
-
NHMRC extensions due to COVID-19 impact on researchers
-
The UK’s EPPI-Centre has released a list of COVID-19 resources
-
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
-
National Medical Stockpile: Supply of experimental medicines to support clinical trials
-
MRFF Grant Opportunity
-
Medical Research Future Fund – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity open for applications – urgent call for research
-
Australian Commission on Safety and Quality in Health Care Health Service Accreditation (AHSSQA) during the COVID-19 pandemic
-
COVID-19 Expert Database
-
CTTI recommendations for best practice in clinical trials during COVID-19 pandemic
-
New South Wales Office for Health and Medical Research COVID-19 Guidance
-
Australian Commission on Safety and Quality in Health Care extends timeline for National Clinical Trials Governance Pilot due to COVID-19 pandemic